Merit Medical Systems, Inc. (MMSI) Balance Sheet

The decline in leverage appears driven more by equity accumulation from retained earnings, which rose from $639.1M to $946.1M, than by debt repayment, since total debt has remained broadly flat near $820M. This pattern suggests internally generated profits are compounding the equity base rather than management actively deleveraging. Investors should monitor whether this equity-led strengthening continues if acquisition spending re-accelerates.

Debt has been held essentially flat around $820M for most of the period, with a modest step-up to $898M at 2025Q4 before reverting, indicating a stable rather than expanding borrowing profile. Given that interest-bearing obligations are small relative to equity, refinancing risk appears limited near term. The leverage profile may reflect a deliberate choice to preserve capacity for tuck-in acquisitions rather than a constraint on operations.

The increase in goodwill alongside a growing PPE base, which reached $521.7M, suggests the asset mix is shifting toward acquired intangibles and fixed manufacturing capacity. Because goodwill is not amortized under current accounting but is tested for impairment, a deterioration in acquired business performance could produce a non-cash write-down that would compress reported equity. Investors may wish to track segment-level returns on acquired assets to judge whether the goodwill balance is supported by earnings.

A current ratio above 4 and cash balances that have generally trended upward from $343.9M in 2025Q2 suggest strong near-term liquidity relative to current obligations. The volatility in the ratio appears partly linked to working capital movements rather than a structural weakening. This liquidity buffer appears more than adequate to absorb operating shocks without reliance on external financing.